Literature DB >> 16481343

FcRn mediates elongated serum half-life of human IgG in cattle.

Imre Kacskovics1, Zsuzsanna Kis, Balázs Mayer, Anthony P West, Noreen E Tiangco, Mulualem Tilahun, László Cervenak, Pamela J Bjorkman, Richard A Goldsby, Ottó Szenci, Lennart Hammarström.   

Abstract

IgG has the longest survival time in the circulation of the Ig classes and the lowest fractional catabolic rate. The neonatal Fc receptor (FcRn) plays an important role in regulating these processes. Recently, we have cloned the bovine neonatal Fc receptor (bFcRn) alpha chain and detected its expression in various epithelial cells which are mediating IgG secretion. However, its function in IgG homeostasis has not been investigated. In the current study, we analyzed the binding affinity of bovine and human IgGs to bFcRn using surface plasmon resonance and by in vitro radioreceptor binding assays. As human IgG binds stronger to the bFcRn, than bovine IgG at pH 6, we subsequently analyzed its catabolism in normal and transchromosomic calves that produce human Igs. Pharmacokinetic studies showed that human IgG had approximately 33 days serum half-life both in normal and transchromosomic calves, which is more than two times longer than its bovine counterpart. We also demonstrate FcRn expression in endothelial cells and in the kidney which are supposed to be involved in IgG metabolism. These data suggest that bFcRn is involved in IgG homeostasis in cattle and furthermore, that the transchromosomic calves producing human Igs can effectively protect their human IgGs which have implications for successful large-scale production of therapeutic antibodies.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16481343     DOI: 10.1093/intimm/dxh393

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  22 in total

Review 1.  Recent advances using FcRn overexpression in transgenic animals to overcome impediments of standard antibody technologies to improve the generation of specific antibodies.

Authors:  Imre Kacskovics; Judit Cervenak; Anna Erdei; Richard A Goldsby; John E Butler
Journal:  MAbs       Date:  2011-09-01       Impact factor: 5.857

2.  An Extended Minimal Physiologically Based Pharmacokinetic Model: Evaluation of Type II Diabetes Mellitus and Diabetic Nephropathy on Human IgG Pharmacokinetics in Rats.

Authors:  Gurkishan S Chadha; Marilyn E Morris
Journal:  AAPS J       Date:  2015-08-15       Impact factor: 4.009

3.  Effect of Type 2 Diabetes Mellitus and Diabetic Nephropathy on IgG Pharmacokinetics and Subcutaneous Bioavailability in the Rat.

Authors:  Gurkishan S Chadha; Marilyn E Morris
Journal:  AAPS J       Date:  2015-04-30       Impact factor: 4.009

4.  Design, expression and characterization of a soluble single-chain functional human neonatal Fc receptor.

Authors:  Yang Feng; Rui Gong; Dimiter S Dimitrov
Journal:  Protein Expr Purif       Date:  2011-03-29       Impact factor: 1.650

5.  Cross-reactive HIV-1-neutralizing activity of serum IgG from a rabbit immunized with gp41 fused to IgG1 Fc: possible role of the prolonged half-life of the immunogen.

Authors:  Mei-Yun Zhang; Yanping Wang; Marie K Mankowski; Roger G Ptak; Dimiter S Dimitrov
Journal:  Vaccine       Date:  2008-12-10       Impact factor: 3.641

6.  Position independent and copy-number-related expression of the bovine neonatal Fc receptor alpha-chain in transgenic mice carrying a 102 kb BAC genomic fragment.

Authors:  Balázs Bender; Lilla Bodrogi; Balázs Mayer; Zita Schneider; Yaofeng Zhao; Lennart Hammarström; André Eggen; Imre Kacskovics; Zsuzsanna Bosze
Journal:  Transgenic Res       Date:  2007-06-27       Impact factor: 2.788

7.  NFκB induces overexpression of bovine FcRn: a novel mechanism that further contributes to the enhanced immune response in genetically modified animals carrying extra copies of FcRn.

Authors:  Judit Cervenak; Márton Doleschall; Balázs Bender; Balázs Mayer; Zita Schneider; Zoltán Doleschall; Yaofeng Zhao; Zsuzsanna Bősze; Lennart Hammarström; Wolfgang Oster; Imre Kacskovics
Journal:  MAbs       Date:  2013 Nov-Dec       Impact factor: 5.857

Review 8.  Colostrogenesis: IgG1 transcytosis mechanisms.

Authors:  Craig R Baumrucker; Rupert M Bruckmaier
Journal:  J Mammary Gland Biol Neoplasia       Date:  2014-01-29       Impact factor: 2.673

9.  Over-expression of the bovine FcRn in the mammary gland results in increased IgG levels in both milk and serum of transgenic mice.

Authors:  Wei Lu; Zhihui Zhao; Yaofeng Zhao; Shuyang Yu; Yiqiang Zhao; Baoliang Fan; Imre Kacskovics; Lennart Hammarström; Ning Li
Journal:  Immunology       Date:  2007-07-03       Impact factor: 7.397

10.  Evaluation of a catenary PBPK model for predicting the in vivo disposition of mAbs engineered for high-affinity binding to FcRn.

Authors:  Yang Chen; Joseph P Balthasar
Journal:  AAPS J       Date:  2012-09-07       Impact factor: 4.009

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.